On 1 June 2024 CNB expanded the definition of 'cannabinol derivatives' in the Misuse of Drugs Act to cover hexahydro derivatives, semi-synthetic cannabinoids reported to have the same effects as THC.[1] The same date brought the psychoactive substance framework into force, allowing action against unscheduled synthetic drugs that mimic cannabis.[2] Cannabis itself remained a Class A controlled drug in the First Schedule.[1]
Listed for context. No score change is recorded for Singapore here.
References
- Central Narcotics Bureau — Amendments to the First Schedule of the Misuse of Drugs Act (31 May 2024)Paras 1–2 and 6; Annex Barchived
- Ministry of Home Affairs — Commencement of the Misuse of Drugs (Amendment) Act 2023 [Second Tranche] and Constitution of the Republic of Singapore (Amendment) Act 2023 (31 May 2024)Paras 2–4
Checked. The date and the event were compared with a source that was read.